Jonathan Birchall

Chief Commercial Officer

Jonathan has over 25 years of experience in the biopharmaceuticals industry, including building and leading commercial teams in the United States and the United Kingdom. He joins PhaseBio after 12 years at Genentech where, most recently, he was Vice President and U.S. Head of the company’s thrombolytics franchise. Prior to this role, Jonathan was Lifecycle Leader for the global launch of Kadcyla® and also served as Marketing Director and National Sales Director in the respiratory franchise. Before joining Genentech, Jonathan worked at Sanofi Aventis for 15 years, initially as a sales representative in the United Kingdom before taking on numerous commercial roles with increasing responsibility including Global Marketing Director, and ultimately serving as Business Unit Head in the U.K.

Jonathan will lead PhaseBio’s efforts to build a critical-care focused commercial organization to support the U.S. launch of bentracimab. The company is targeting to submit its Biologics License Agreement with the FDA in mid-2022 , which, if approved, could position U.S. launch of bentracimab in early 2023.

Jonathan received a BSc in Sport Administration and Science from Nottingham Trent University. He also received a MSc in Marketing from The University of Salford and an MBA from The Open University.